Article info
Review
Metabolic phenotyping and cardiovascular disease: an overview of evidence from epidemiological settings
- Correspondence to Professor Paul Elliott, MRC-HPA Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of Science Technology and Medicine, London W2 1PG, UK; p.elliott{at}imperial.ac.uk
Citation
Metabolic phenotyping and cardiovascular disease: an overview of evidence from epidemiological settings
Publication history
- Received October 15, 2020
- Revised January 5, 2021
- Accepted January 8, 2021
- First published February 19, 2021.
Online issue publication
June 25, 2021
Article Versions
- Previous version (19 February 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.